Naproxen

Product manufactured by Proficient Rx Lp

Application Nr Approved Date Route Status External Links
ANDA091432 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Carefully Consider The Potential Benefits And Risks Of Naproxen Delayed-Release Tablets And Other Treatment Options Before Deciding To Use Naproxen Delayed-Release Tablets. Use The Lowest Effective Dosage For The Shortest Duration Consistent With Individual Patient Treatment Goals ( See Warnings: Gastrointestinal Bleeding, Ulceration, And Perforation ). Naproxen Delayed-Release Tablets Are Indicated: • For The Relief Of The Signs And Symptoms Of Rheumatoid Arthritis • For The Relief Of The Signs And Symptoms Of Osteoarthritis • For The Relief Of The Signs And Symptoms Of Ankylosing Spondylitis • For The Relief Of The Signs And Symptoms Of Juvenile Arthritis Naproxen Delayed-Release Tablets Are Not Recommended For Initial Treatment Of Acute Pain Because The Absorption Of Naproxen Is Delayed Compared To Absorption From Other Naproxen-Containing Products (See Clinical Pharmacology , Dosage And Administration ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Naproxen NAPROXEN ZINC105216

Comments